VSee Health Inc. outlined plans to achieve $1 million in annual savings after its recent delisting from Nasdaq, reallocating the funds toward revenue-generating initiatives and hospital-based telehealth expansion.
The Houston-based company, which operates telehealth technology and specialty physician services through its iDoc subsidiary, cited the shift from public-company compliance costs as a key driver of the savings target. VSee also aims to improve collection on approximately $8 million in recently billed healthcare accounts receivable as part of its operational adjustments.
Shareholders approved an 80-to-1 reverse stock split during the company’s annual meeting, alongside the appointment of auditors WWC and the renewal of two board members. VSee provides services in neurology, tele-radiology, cardiac, and critical care, with plans to accelerate the deployment of several new hospital-based telehealth programs.
The company intends to adopt a new corporate name to better reflect its focus on hospital-based healthcare services, pending board, stockholder, and regulatory approvals. Chief Executive Officer Imo Aisiku, M.D., stated that while the delisting was disappointing, the company sees opportunities to invest savings directly into revenue-generating initiatives and customer support.
VSee Health’s stock has faced volatility amid its delisting and restructuring efforts, reflecting broader challenges in the telehealth sector’s transition from pandemic-era growth to sustainable operations.
